NICE NICE 深 沪
等待开盘 12-19 09:30:00 美东时间
108.84
+0.210
+0.19%
华盛通- 最 高110.255
- 今 开109.45
- 成交量 68.85万股
- 最 低 108.2701
- 昨 收 108.63
- 总市值 67.20亿
- 52周最高 180.61
- 市盈率 静 16.03
- 换手率 0.00%
- 52周最低 99.00
- 委 比 64.04%
- 总股本 6174.35万
- 历史最高 319.88
- 量 比 1.33
- 振 幅 1.83%
- 历史最低 25.724
- 每 手 1
- 风险率 19.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多锦和商管园区可持续假日序章，践行ESG理念，重塑节日之美
2025 · HEY CHRISTMAS 锦和商管旗下各园区 早已悄悄换上了ESG理念的节日新装 这一次，我们选择以更具创意、更贴近自然的方式在每一个细节中践行...
12-11 13:32
Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease
Heartflow的FFRCT技术在英国NHS的研究中显示出出色的临床和经济价值。该技术能有效预测心血管事件风险并减少医疗成本。研究显示，使用FFRCT可降低不必要的检查，节省每位患者约1384美元的医疗费用，为英国NHS每年节省3345万美元。FFRCT通过无创AI技术精准评估冠状动脉疾病，已在超过100项研究中得到验证，并被1400多家机构采用。
12-11 08:10
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
12-09 10:32
Wedbush Downgrades NICE to Neutral, Lowers Price Target to $120
Wedbush analyst Dan Ives downgrades NICE (NASDAQ:NICE) from Outperform to Neutral and lowers the price target from $170 to $120.
12-08 22:11
Intel, Qualcomm, Adobe, others seen as 'AI losers,' Wedbush says
Artificial intelligence is completely altering how various industries spend their money, benefiting companies such as Nvidia (NVDA), AMD (AMD) and others. And while there may be some winners, Wedbush ...
12-08 20:42
A Glimpse of Descartes Systems Gr's Earnings Potential
Descartes Systems Gr (NASDAQ:DSGX) is preparing to release its quarterly earnin...
12-02 23:01
药品零关税换取涨价！美国抢在最高法院裁决前与英国锁定协议
特朗普一直向英国施压，要求该国为美国药物支付更高的价格，如今他得偿所愿！英国商会表示，药品出口仅占英国对美出口总值的约五分之一，但英国获得了一份很少有国家能达成的协议。
12-02 22:00
美国与英国达成药品零关税协议
美国与英国于周一宣布达成一项协议：英国药品及医疗技术产品将获得美国零关税待遇，作为交换，英国需增加药品支出，并全面改革药品价值评估体系。 根据协议，英国...
12-02 05:43
Why Is Autolus Therapeutics Stock Trading Higher On Tuesday?
U.K.'s NICE issues draft guidance recommending Autolus' Aucatzyl for adult r/r B-ALL, setting up imminent NHS launch and broader patient access.
11-26 01:37
Nanox.AI Bone Solutions, Advanced AI-Powered Software for Spine Assessment, Recommended by NICE for Early Value Assessment in UK National Health Service hospitals
Nanox.AI's HealthOST and HealthVCF have been recommended by NICE for use in UK NHS hospitals for three years to evaluate AI's role in detecting vertebral fragility fractures. These solutions, which analyze existing CT scans to detect VFFs without additional imaging, aim to improve early detection and treatment of bone diseases. NICE and experts highlight the potential of AI to enhance fracture detection and improve patient outcomes, making these ...
11-24 13:10
